| 摘要 |
FIELD: medicine. ^ SUBSTANCE: group of inventions refers to medicine, and concerns multiple vaccination including serogroup C meningococci. Substance of the group of inventions involves an immunisation kit containing a first immunogenic component representing a conjugated capsular saccharide of the strain OAc+ Neisseria meningitides serogroup C and a lyophilised conjugated antigen Hib, and a second immunogenic component containing an aqueous formulation of diphtheria toxoid, tetanus toxoid and cell-free antigen B. pertussis. The invention also involves the application of the lyophilised capsular saccharide of the strain OAc+ Neisseria meningitides serogroup C conjugated with the carrier-protein tetanus toxoid and the aqueous cell-free antigen B. pertussis, for preparing an immunisation drug. ^ EFFECT: advantage of the group of inventions consists in developing the vaccine kits which are able to ensure MenC protection as a component of combined vaccines without loss of immunogenicity. ^ 31 cl |
